Mutagenesis vol. 8 no. 3 pp. 265-271, 1993
© 1993 UK Environmental Mutagen Society/Oxford University Press
research-article |
Induction of hepatic mutations in lacI transgenic mice
SRI International 333 Ravenswood Avenue, Menlo Park, CA 94025 1Stratagene Cloning System La Jolla, CA 92037, USA
Transgenic B6C3F1 and C57BL/6 mice containing a lambda shuttle vector that carries a lacI target and an 
lacZ reporter gene have been constructed for use in in vivo mutagenesis assays. After chemical treatment of mice carrying the lacI target gene genomic, DNA is isolated and the shuttle vector is recovered by exposing the DNA to lambda phage packaging extracts in vitro. Mutations in the lacI target gene that inactivate the repressor gene allow expression of the lacZ reporter gene, resulting in blue mutant plaques. We have examined the ability of two genotoxic agents, dimethylnitrosamine (DMN) and methylmethane sulfonate (MMS), to induce mutations in these transgenic mice. Both compounds induce a variety of DNA adducts in mouse liver; DMN is a hepatocarcinogen that induces significant hepatic cell proliferation, but MMS is not hepatocarcinogenic and does not induce hepatic cell proliferation. The effects of animal age, differences in strain and dosing regimen, and length of expression time were evaluated. Mice were treated for 5, 14 or 21 days and were sacrificed 1, 8 or 22 days after the final dose to evaluate the effects of increased expression time on mutant frequency in liver. In 3 week old mice, DMN(2 mg/kg/day) produced 10- to 20-fold elevations in mutant frequency that increased with expression time and the number of treatments. In contrast, MMS (20 mg/kg/day) failed to increase the mutant frequency. DMN failed to induce mutations in 6 week old mice at 2 mg/kg/day, but 4 mg/kg/dayyielded significant elevations in hepatic mutations. Sequencing results indicate that treatment of mice with DMN produced predominantly C:G 
T:A transitions. At either 4 or 6 mg/kgDMN per day, both C57BL/6 and B6C3F1 mice yielded comparable mutation frequencies. These results suggest that enhanced cell proliferation and/or mutational spectra may contribute to the hepatocarcinogenic potency of these chemicals.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. T. Macgregor Biomarkers of Cancer Risk and Therapeutic Benefit: New Technologies, New Opportunities, and Some Challenges Toxicol Pathol, January 1, 2004; 32(1_suppl): 99 - 105. [Abstract] [PDF]
|
|
|
|
 |
|
 R. N. Winn, M. B. Norris, K. J. Brayer, C. Torres, and S. L. Muller Detection of mutations in transgenic fish carrying a bacteriophage lambda cII transgene target PNAS, October 12, 2000; (2000) 220428097. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Davies, B. Clothier, and A. G. Smith Mutation frequency in the lacI gene of liver DNA from lambda/lacI transgenic mice following the interaction of PCBs with iron causing hepatic cancer and porphyria Mutagenesis, September 1, 2000; 15(5): 379 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.S. Shane, J.G. deBoer, B.W. Glickman, and M.L. Cunningham Oxazepam is mutagenic in vivo in Big Blue(R) transgenic mice Carcinogenesis, July 1, 1999; 20(7): 1315 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Tombolan, D. Renault, D. Brault, M. Guffroy, O. Perin-Roussel, F. Perin, and V. Thybaud Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of Muta(TM)Mice treated with 5,9-dimethyldibenzo[c,g]carbazole Carcinogenesis, January 1, 1999; 20(1): 125 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Schiestl, J. Aubrecht, F. Khogali, and N. Carls Carcinogens induce reversion of the mouse pink-eyed unstable mutation PNAS, April 29, 1997; 94(9): 4576 - 4581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ashby Alternatives to the 2-species bioassay for the identification of potential human carcinogens Human and Experimental Toxicology, March 1, 1996; 15(3): 183 - 202. [Abstract] [PDF]
|
|
|
|
|
|
R. N. Winn, M. B. Norris, K. J. Brayer, C. Torres, and S. L. Muller Detection of mutations in transgenic fish carrying a bacteriophage lambda cII transgene target PNAS, November 7, 2000; 97(23): 12655 - 12660. [Abstract] [Full Text] [PDF]
|
|